HCW Biologics Inc. at its 2023 Annual Meeting of Stockholders approved the election of Rick S. Greene as Class II director to serve for a three-year term expiring at the 2026 Annual Meeting of Stockholders or until such director's successor is duly elected and qualified or until such director's earlier death, resignation, disqualification or removal.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 USD | -0.71% | -12.70% | +14.29% |
Apr. 01 | HCW Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 01 | HCW Biologics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.29% | 53.33M | |
-3.46% | 102B | |
+1.41% | 96.29B | |
+2.13% | 22.18B | |
-15.84% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.65% | 16.36B | |
+4.39% | 13.97B | |
+31.35% | 12.17B |
- Stock Market
- Equities
- HCWB Stock
- News HCW Biologics Inc.
- Hcw Biologics Inc. Announces Appointment of Rick S. Greene as Class II Director